a_serpaneto Profile Banner
Ary Serpa Neto Profile
Ary Serpa Neto

@a_serpaneto

Followers
759
Following
3K
Media
29
Statuses
255

Senior Research Fellow, ANZIC-RC, Monash University Professor, Researcher and Intensivist, HIAE A/Prof, University of São Paulo

Melbourne
Joined February 2020
Don't wanna be here? Send us removal request.
@a_serpaneto
Ary Serpa Neto
1 month
RT @chodgsonANZICRC: Editor in Chief ⁦@NEJM⁩ speaking at #PratoICM25 about “why we should believe what we read” and how we deal with resear….
0
11
0
@a_serpaneto
Ary Serpa Neto
2 months
RT @CritCareReviews: In memory of professor Rinaldo Bellomo: A giant of intensive care medicine. CCR Journal Watch - tracking the critical….
0
24
0
@a_serpaneto
Ary Serpa Neto
2 months
RT @DogICUma: In memory of professor Rinaldo Bellomo: A giant of intensive care medi.
0
20
0
@a_serpaneto
Ary Serpa Neto
2 months
Tweet media one
0
2
6
@a_serpaneto
Ary Serpa Neto
5 months
RT @jones_daza: Our RRT handbook on deteriorating patients has now been translated into Portuguese .Thx to our translators . Danilo Martin….
0
7
0
@a_serpaneto
Ary Serpa Neto
7 months
RT @EJA_Journal: From @a_serpaneto . A win ratio approach was feasible to apply in a post hoc analysis of three large multicentre studies,….
0
7
0
@a_serpaneto
Ary Serpa Neto
7 months
RT @FOAMecmo: Hospital-level volume in #ECMO cases?.🔎 > 1.2 patients in 🇦🇺 & 🇳🇿.⚖️ no difference in six-month death or new disability betwe….
0
22
0
@a_serpaneto
Ary Serpa Neto
10 months
RT @ATSBlueEditor: Thanks to Ary Serpa Neto, MD, MSc, PhD, for his contribution to the September 15 issue. Impact of High-Dose Early Mobil….
0
1
0
@a_serpaneto
Ary Serpa Neto
1 year
RT @msiuba: Not at #ATS2024, but relevant. Hot off the press @journal_CHEST and open access!. "Differential Effect of PEEP Strategies in….
0
45
0
@a_serpaneto
Ary Serpa Neto
1 year
RT @Michelle_ICU: @chodgsonANZICRC presenting at #ATS2024 on the importance of identifying individual treatment effects - high intensity ex….
0
7
0
@a_serpaneto
Ary Serpa Neto
1 year
RT @ICUnutrition: Congratulations to @Michelle_ICU @chodgsonANZICRC @a_serpaneto and team on this pub and a spot in the #isicem24 @ISICEM p….
0
1
0
@a_serpaneto
Ary Serpa Neto
1 year
RT @chodgsonANZICRC: #ISICEM24 with @Michelle_ICU opening plenary: We found no relationship between adverse events and early mobilisation….
0
16
0
@a_serpaneto
Ary Serpa Neto
1 year
RT @Michelle_ICU: So humbled to be able to share our recent review in the opening plenary at #isicem24 that showed the safety of early mobi….
0
9
0
@a_serpaneto
Ary Serpa Neto
1 year
RT @SODa_BIC: Congratulations to Wellington Regional Hospital for randomising SODa-BIC's 20th participant! 🇳🇿🥳
Tweet media one
0
1
0
@a_serpaneto
Ary Serpa Neto
1 year
RT @SODa_BIC: SODa-BIC has reached double digits! .Congratulations to Sultan Qaboos Comprehensive Cancer Care & Research Center for recruit….
0
2
0
@a_serpaneto
Ary Serpa Neto
1 year
PROVE (@ProvenetNetwork) Network Unveils New Website . PROVE Network, founded by Paolo Pelosi, Marcelo Gama de Abreu, Marcus Schultz, Sabrine Hemmes, and Ary Serpa Neto, has led impactful multicenter clinical studies in ventilation. Dive in now:
0
0
7
@a_serpaneto
Ary Serpa Neto
2 years
RT @tomrollinsonPT: Excited to share some of our findings on #prone positioning in pts with #covid 🦠requiring mech vent in Aust: P/F ratio….
0
12
0
@a_serpaneto
Ary Serpa Neto
2 years
PROTHOR stands as the largest clinical trial on mechanical ventilation to date, made possible by the efforts of individuals worldwide committed to advancing evidence-based clinical practices. A PROVEnet undertaking, in collaboration with ESAIC, EACTAIC, and over 80 sites.
Tweet media one
0
3
11
@a_serpaneto
Ary Serpa Neto
2 years
RT @caiodeamtavares: DEFENDER study design has just been published. Results coming Q1/2024. Stay tuned!! @OtavioBe….
0
2
0
@a_serpaneto
Ary Serpa Neto
2 years
RT @SODa_BIC: Congratulations to the team at the Austin for randomising their first participant! 🥳.
0
2
0